PHARMACOTHERAPIES FOR ALCOHOL ABUSE
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Pharmacologic management of alcoholism is only one part of the management of both alcohol dependence and withdrawal, which also includes the provision of a calm, quiet environment; reassurance; ongoing reassessment; attention to fluid and electrolyte disorders; treatment of coexisting addictions and common medical, surgical, and psychiatric comorbidities; and referral for ongoing psychosocial and medical treatment. For further discussion of these topics, the reader is referred to previously published sources. A survey of alcoholism treatment programs revealed that although benzodiazepines were the most commonly used drugs, standardized monitoring of patients' withdrawal severity was not common practice, and a significant minority of clinicians were using a variety of other drugs, some not known to prevent or treat the complications of withdrawal. Treatment should be based on the available evidence (Working Group on Pharmacological Management of Alcohol Withdrawal: American Society of Addiction Medicine Committee on Practice Guidelines: Pharmacological management of alcohol withdrawal: An evidence-based practice guideline. Unpublished draft, 1997). Patients with significant symptoms, patients with complications such as seizures or delirium tremens, and patients at higher risk for complications of alcohol withdrawal should receive benzodiazepines, particularly chlordiazepoxide, diazepam, or lorazepam, because of their safety and documented efficacy in preventing and treating the most serious complications of alcohol withdrawal. These drugs may be dosed on a fixed schedule for a predetermined number of doses on a tapering schedule over several days, or they may be administered by front-loading. An alternative approach for selected patients without seizures or acute comorbidity is symptom-triggered therapy, which individualizes treatment and decreases the duration and dose of medication administration. With either of the regimens, patients should have their withdrawal severity monitored until symptoms are resolving. Once withdrawal from alcohol is safely completed, the focus should turn to helping to prevent relapse. Disulfiram may be useful in highly motivated subsets of patients and when compliance-enhancing strategies are used. Naltrexone is useful in the broader population of patients entering treatment for alcohol dependence. These pharmacologic interventions should be given in the context of ongoing psychosocial support. There is substantial evidence that pharmacologic management of alcohol abuse and dependence is effective. As would be predicted from alcohol's myriad cellular effects, no panacea exists for alcoholism. For alcohol withdrawal, however, although treatment regimens have only recently been refined, evidence for effective treatment of symptoms and prevention of complications with benzodiazepines has been available for decades. Within the last decade, effective treatments, including naltrexone, have been shown to reduce alcohol intake in alcohol-dependent persons. Given the prevalence and cost of alcohol-related problems, all effective therapies (including pharmacologic treatments) should be considered to treat alcohol abuse and dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Kindling as a Model for Alcohol Withdrawal Syndromes
Ballenger, J. C., & Post, R. M. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.1.1 · Cited by 463
Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.1986.03380110055026 · Cited by 431
Use of benzodiazepines in anxiety disorders
Wood, A. J. J., Shader, R. I., & Greenblatt, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281907 · Cited by 341
Effect of naltrexone on alcohol “high” in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.613 · Cited by 308
Naltrexone-induced alterations in human ethanol intoxication
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1463 · Cited by 254
Alcohol withdrawal syndromes: A review of pathophysiology, clinical presentation, and treatment
Turner, R. C., Lichstein, P. R., Peden, J. G., Busher, J. T., & Waivers, L. E. (1989) · Journal of General Internal Medicine · doi:10.1007/bf02599697 · Cited by 108
Research works printed but not linked: 150
- Allan, 1987, Involvement of neuronal chloride channels in ethanol intoxication, tolerance, and dependence, 313, 10.1007/978-1-4899-1684-6_12 · DOI
- Alldredge, 1993, Status epilepticus related to alcohol abuse, Epilepsia, 34, 1033, 10.1111/j.1528-1157.1993.tb02130.x · DOI · Paper page
- Alldredge, 1989, Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures, Am J Med, 87, 645, 10.1016/S0002-9343(89)80397-3 · DOI
- Annis, 1991, A cognitive-social learning approach to relapse: Pharmacotherapy and relapse prevention counseling, Alcohol Alcohol, 527
- Baekeland, 1971, Correlates of outcome in disulfiram treatment of alcoholism, J Nerv Ment Dis, 153, 1, 10.1097/00005053-197107000-00001 · DOI · Paper page
- Banki, 1983, Comparative study with grandaxin and diazepam in alcohol withdrawal syndrome and gerontopsychiatric diseases, Ther Hung, 31, 120
- Baumgartner, 1987, Clonidine versus chlordiazepoxide in the management of the acute alcohol withdrawal syndrome, Arch Intern Med, 147, 1223, 10.1001/archinte.1987.00370070037005 · doi:10.1001/archinte.1987.00370070037005 · Paper page
- Benzer, 1990, Quantification of the alcohol withdrawal syndrome in 487 alcoholic patients, J Subst Abuse Treat, 7, 117, 10.1016/0740-5472(90)90007-D · DOI
- Bezzegh, 1991, Alpha-atrial natriuretic peptide, aldosterone secretion and plasma renin activity during alcohol withdrawal: A correlation with the onset of delirium tremens?, Alcohol, 8, 333, 10.1016/0741-8329(91)90513-V · DOI
- Bjorkqvist, 1975, Clonidine in alcohol withdrawal, Acta Psychiatr Scand, 52, 256, 10.1111/j.1600-0447.1975.tb00041.x · DOI · Paper page
- Bjorkvist, 1976, Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: A formal multicentre double-blind comparison with placebo, Acta Psychiatr Scand, 53, 333, 10.1111/j.1600-0447.1976.tb00081.x · DOI · Paper page
- Booth, 1993, The kindling hypothesis: Further evidence from a U.S. national study of alcoholic men, Alcohol Alcohol, 28, 593
- Bowman, 1966, Treatment of alcoholism in the subacute stage: A study of three active agents, Dis Nerv Syst, 27, 342
- Brewer, 1984, How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice, Br J Psychiatry, 144, 200, 10.1192/bjp.144.2.200 · DOI · Paper page
- Brower, 1994, Severity and treatment of alcohol withdrawal in elderly versus younger patients, Alcohol Clin Exp Res, 18, 196, 10.1111/j.1530-0277.1994.tb00903.x · DOI · Paper page
- Brown, 1988, Alcohol detoxification and withdrawal seizures: Clinical support for a kindling hypothesis, Biol Psychiatry, 23, 507, 10.1016/0006-3223(88)90023-6 · DOI · Paper page
- Buchsbaum, 1991, Screening for alcohol abuse using CAGE scores and likelihood ratios, Ann Intern Med, 115, 774, 10.7326/0003-4819-115-10-774 · DOI · Paper page
- Buchsbaum, 1991, Alcohol consumption patterns in a primary care population, Alcohol Alcohol, 26, 215, 10.1093/oxfordjournals.alcalc.a045103 · DOI
- Buchsbaum, 1992, Physician detection of drinking problems in patients attending a general medicine practice, J Gen Intern Med, 7, 517, 10.1007/BF02599456 · DOI
- Burroughs, 1985, Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms, Alcohol Alcohol, 20, 263
- Chambers, 1965, Double-blind study of three drugs in the treatment of acute alcoholic states, Q J Stud Alcohol, 26, 10, 10.15288/qjsa.1965.26.010 · DOI
- Chance, 1991, Emergency department treatment of alcohol withdrawal seizures with phenytoin, Ann Emerg Med, 20, 520, 10.1016/S0196-0644(05)81606-3 · DOI
- Chu, 1979, Carbamazepine: Prevention of alcohol withdrawal seizures, Neurology, 29, 1397, 10.1212/WNL.29.10.1397 · DOI · Paper page
- Ciraulo, 1981, Imipramine disposition in alcoholics, J Clin Psychopharmacol, 68, 819
- Clothier, 1985, Varying rates of alcohol metabolism in relation to detoxification medication, Alcohol, 2, 443, 10.1016/0741-8329(85)90112-0 · doi:10.1016/0741-8329(85)90112-0
- Cornelius, 1993, Fluoxetine trial in suicidal depressed alcoholics, Psychopharmacol Bull, 29, 195
- Croop RS, Labriola DF, Wroblewski JM, et al: A multicenter safety study of naltrexone as adjunctive pharmacotherapy for individuals with alcoholism. Presented at Annual Meeting of the American Psychiatric Association, Miami, 1995 · doi:10.1016/0924-977x(95)90742-v
- Daoust, 1992, Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats, Pharmacol Biochem Behav, 41, 669, 10.1016/0091-3057(92)90210-7 · DOI
- Daryanani, 1994, Alcoholic withdrawal syndrome and seizures, Alcohol Alcohol, 29, 323
- D'Onofrio, 1995, Lorazepam prevents recurrent alcohol-related seizures [abstr], Acad Emerg Med, 2, 368
- Engle, 1972, Effect of an ounce of vodka on alcoholics' desire for alcohol, Q J Stud Alcohol, 33, 1099, 10.15288/qjsa.1972.33.1099 · DOI · Paper page
- Farren C, O'Malley SS, Rounsaville BJ: Naltrexone and opiate abuse: Who benefits from it and how to increase its effectiveness. In Stine S, Kosten T (eds): New Treatments for Opiate Dependence: Which Treatments for Which Patients. New York, Guildford Press, in press
- Ferguson, 1996, Risk factors for delirium tremens development, J Gen Intern Med, 11, 410, 10.1007/BF02600188 · DOI · Paper page
- Foy, 1988, Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital, Alcohol Clin Exp Res, 12, 360, 10.1111/j.1530-0277.1988.tb00208.x · DOI · Paper page
- Gerra, 1992, Effects of fluoxetine and CA-acetyl-homotaurinate on alcohol intake in familial and non-familial alcoholic patients, Curr Ther Res, 52, 291, 10.1016/S0011-393X(05)80480-1 · DOI
- Golbert, 1967, Comparative evaluation of treatments of alcohol withdrawal syndromes, JAMA, 201, 113, 10.1001/jama.1967.03130020045009 · DOI · Paper page
- Gold, 1980, Opiate withdrawal using clonidine, JAMA, 243, 343, 10.1001/jama.1980.03300300021018 · doi:10.1001/jama.1980.03300300021018 · Paper page
- Gordis, 1996, Alcohol research: At the cutting edge, Arch Gen Psychiatry, 53, 199, 10.1001/archpsyc.1996.01830030017004 · doi:10.1001/archpsyc.1996.01830030017004
- Grant, 1994, Alcohol consumption, alcohol abuse and alcohol dependence: The United States as an example, Addiction, 89, 1357, 10.1111/j.1360-0443.1994.tb03730.x · DOI
- Greenblatt, 1983, Current status of benzodiazepines, N Engl J Med, 309, 410, 10.1056/NEJM198308183090705 · DOI · Paper page
- Griffiths, 1990, Relative abuse potential of different benzodiazepines in drug abusers, J Clin Psychopharmacol, 10, 237, 10.1097/00004714-199008000-00002 · DOI · Paper page
- Harper, 1979, Wernicke's encephalopathy: A more common disease than realized: A neuropathological study of 51 cases, J Neurol Neurosurg Psychiatry, 42, 226, 10.1136/jnnp.42.3.226 · DOI · Paper page
- Hatsukami, 1982, Posttreatment depression in an alcohol and drug abuse population, Am J Psychiatry, 139, 1563, 10.1176/ajp.139.12.1563 · DOI
- Hayashida, 1989, Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome, N Engl J Med, 320, 358, 10.1056/NEJM198902093200605 · DOI · Paper page
- Helzer, 1988, The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment, J Stud Alcohol, 49, 219, 10.15288/jsa.1988.49.219 · DOI · Paper page
- Hill, 1993, Hazards associated with the use of benzodiazepines in alcohol detoxification, J Subst Abuse Treat, 10, 449, 10.1016/0740-5472(93)90005-M · DOI
- Hoey, 1994, A prospective evaluation of benzodiazepine guidelines in the management of patients hospitalized for alcohol withdrawal, Pharmacotherapy, 14, 579, 10.1002/j.1875-9114.1994.tb02854.x · DOI
- Hyman, 1995, Current treatment for alcohol withdrawal, J Gen Intern Med, 10, 523, 10.1007/BF02602408 · doi:10.1007/bf02602408
- Isbell, 1955, An experimental study of the etiology of “rum fits” and delirium tremens, Q J Stud Alcohol, 16, 1, 10.15288/qjsa.1955.16.001 · DOI · Paper page
- Jaffe, 1996, Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching, J Consult Clin Psychology, 64, 1044, 10.1037/0022-006X.64.5.1044 · DOI
- Jessup, 1987, Treatment of the pregnant alcohol-dependent woman, J Psychoactive Drugs, 19, 193, 10.1080/02791072.1987.10472403 · DOI
- Kaim, 1969, Treatment of the acute alcohol withdrawal state: A comparison of four drugs, Am J Psychiatry, 125, 1640, 10.1176/ajp.125.12.1640 · DOI · Paper page
- Kamerow, 1986, Alcohol abuse, other drug abuse and mental disorders in medical practice, JAMA, 255, 2054, 10.1001/jama.1986.03370150096035 · DOI · Paper page
- Kessler, 1994, Lifetime and 12-month prevalence of DSM- III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey, Arch Gen Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
- Kolata, 1986, New drug counters alcohol intoxication, Science, 234, 1198, 10.1126/science.3775379 · DOI
- Kramp, 1978, Delirium tremens: A double-blind comparison of diazepam and barbital treatment, Acta Psychiatr Scand, 58, 174, 10.1111/j.1600-0447.1978.tb06930.x · DOI · Paper page
- Kranzler, 1994, Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism, J Consult Clin Psychol, 62, 1116, 10.1037/0022-006X.62.6.1116 · doi:10.1037/0022-006x.62.6.1116
- Kranzler, 1995, Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics, Am J Psychiatry, 152, 391, 10.1176/ajp.152.3.391 · DOI · Paper page
- Kraus, 1985, Randomized clinical trial of atenolol in patients with alcohol withdrawal, N Engl J Med, 313, 905, 10.1056/NEJM198510103131501 · DOI · Paper page
- Lake, 1977, Increased sympathetic nervous activity in alcoholic patients treated with disulfiram, Am J Psychiatry, 134, 1411, 10.1176/ajp.134.12.1411 · DOI
- Lechtenberg, 1991, Relative kindling effect of detoxification and non-detoxification admissions in alcoholics, Alcohol Alcohol, 26, 221, 10.1093/oxfordjournals.alcalc.a045104 · DOI · Paper page
- Lee, 1985, Age of onset versus duration of problem drinking on the alcohol use inventory, J Stud Alcohol, 46, 398, 10.15288/jsa.1985.46.398 · DOI
- Levin, 1985, The role of magnesium in cardiovascular disorders, Cardiovasc Med, 10, 37
- Levy, 1967, A clinical comparison of disulfiram and calcium carbimide, Am J Psychiatry, 123, 1018, 10.1176/ajp.123.8.1018 · DOI
- Lhuintre, 1985, Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics, Lancet, 1, 1014, 10.1016/S0140-6736(85)91615-0 · DOI · Paper page
- Lhuintre, 1990, Acamprosate appears to decrease alcohol intake in weaned alcoholics, Alcohol Alcohol, 25, 613, 10.1093/oxfordjournals.alcalc.a045057 · DOI · Paper page
- Liskow, 1987, Pharmacological treatment of alcohol intoxication, withdrawal, and dependence: A critical review, J Stud Alcohol, 48, 356, 10.15288/jsa.1987.48.356 · DOI · Paper page
- Liskow, 1989, Alcohol withdrawal in the elderly, J Stud Alcohol, 50, 414, 10.15288/jsa.1989.50.414 · DOI · Paper page
- Lister, 1987, The benzodiazepine receptor inverse agonists FG 7142 and RO 15-4513 both reverse some of the behavioral effects of ethanol in a holeboard test, Life Sci, 41, 1481, 10.1016/0024-3205(87)90713-2 · DOI
- Lister, 1988, Alcohol antagonists—the continuing quest, Alcohol Clin Exp Res, 12, 566, 10.1111/j.1530-0277.1988.tb00243.x · DOI
- Littleton, 1995, Acamprosate in alcohol dependence: How does it work?, Addiction, 90, 1179, 10.1111/j.1360-0443.1995.tb01088.x · DOI · Paper page
- Ludwig, 1974, The first drink: Psychobiological aspects of craving, Arch Gen Psychiatry, 30, 539, 10.1001/archpsyc.1974.01760100093015 · DOI · Paper page
- Lundwall, 1971, Disulfiram treatment of alcoholism, J Nerv Ment Dis, 153, 381, 10.1097/00005053-197112000-00002 · DOI · Paper page
- Malcolm, 1989, Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal, Am J Psychiatry, 146, 617, 10.1176/ajp.146.5.617 · DOI · Paper page
- Marconi, 1960, Comparative clinical study of the effects of disulfiram and calcium carbimide, Am J Psychiatry, 123, 1018
- Martin, 1973, Naltrexone, an antagonist for the treatment of heroin dependence: Effects in man, Arch Gen Psychiatry, 28, 784, 10.1001/archpsyc.1973.01750360022003 · DOI · Paper page
- Mason, 1996, A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression, JAMA, 275, 761, 10.1001/jama.1996.03530340025025 · DOI · Paper page
- Mason, 1994, A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence, Alcohol Clin Exp Res, 18, 1162, 10.1111/j.1530-0277.1994.tb00098.x · DOI · Paper page
- Mayo-Smith, 1995, Late-onset seizures in alcohol withdrawal, Alcohol Clin Exp Res, 19, 656, 10.1111/j.1530-0277.1995.tb01563.x · DOI · Paper page
- McClellan, 1993, The effects of psychosocial services in substance abuse treatment, JAMA, 269, 1953, 10.1001/jama.1993.03500150065028 · DOI · Paper page
- McLean, 1994, Magnesium and its therapeutic uses: A review, Am J Med, 96, 63, 10.1016/0002-9343(94)90117-1 · DOI · Paper page
- Mendels, 1985, Halazepam in the management of acute alcohol withdrawal syndrome, J Clin Psychiatry, 46, 172
- Mendelson, 1969, Effects of alcohol ingestion and withdrawal on magnesium states of alcoholics: Clinical and experimental findings, Ann NY Acad Sci, 162, 918, 10.1111/j.1749-6632.1969.tb13021.x · DOI
- Meyer, 1984, Bioequivalence, dose-proportionality and pharmacokinetics of naltrexone after oral administration, in a new approach to the management of opioid dependence, J Clin Psychiatry, 45, 15
- Miller, 1984, A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of acute alcohol withdrawal syndrome, Clin Ther, 6, 364
- Monti, 1991, Ritanserin decreases alcohol intake in chronic alcoholics, Lancet, 337, 60, 10.1016/0140-6736(91)93386-N · DOI
- Morse, 1992, The definition of alcoholism, JAMA, 268, 1012, 10.1001/jama.1992.03490080086030 · DOI
- Morton, 1994, A prediction model for identifying alcohol withdrawal seizures, Am J Drug Alcohol Abuse, 20, 75, 10.3109/00952999409084058 · DOI · Paper page
- Moskowitz, 1983, Deficiencies of clinical trials of alcohol withdrawal, Alcohol Clin Exp Res, 7, 42, 10.1111/j.1530-0277.1983.tb05409.x · DOI · Paper page
- Naranjo, 1990, Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers, Clin Pharmacol Ther, 47, 490, 10.1038/clpt.1990.62 · DOI · Paper page
- Naranjo, 1983, Nonpharmacologic intervention in acute alcohol withdrawal, Clin Pharmacol Ther, 34, 214, 10.1038/clpt.1983.155 · DOI · Paper page
- Naranjo, 1984, Zimelidine-induced variations in alcohol intake by non-depressed heavy drinkers, Clin Pharmacol Ther, 35, 374, 10.1038/clpt.1984.46 · DOI · Paper page
- Naranjo, 1987, The serotonin uptake inhibitor citalopram attenuates ethanol intake, Clin Pharmacol Ther, 41, 266, 10.1038/clpt.1987.27 · DOI · Paper page
- Nunes, 1993, Imipramine treatment of alcoholism with comorbid depression, Am J Psychiatry, 150, 963, 10.1176/ajp.150.6.963 · DOI · Paper page
- O'Brien, 1996, Naltrexone in the treatment of alcoholism: A clinical review, Alcohol, 13, 35, 10.1016/0741-8329(95)02038-1 · DOI · Paper page
- O'Brien, 1983, Double-blind comparison of lorazepam and diazepam in the treatment of the acute alcohol abstinence syndrome, Curr Ther Res, 34, 825
- O'Connor, 1991, Social and clinical features as predictors of outcome in outpatient alcohol withdrawal, J Gen Intern Med, 6, 312, 10.1007/BF02597427 · DOI
- O'Connor PG, Farren CK, Rounsaville BJ, et al: Treatment of alcohol dependence with naltrexone by primary care providers. In Harris LS (ed): Problems of Drug Dependence 1995: Proceedings of the 57th Annual Scientific Meeting, The College on Problems of Drug Dependence, Rockville, MD, National Institute on Drug Abuse, 1996, p 329
- O'Malley, 1995, Integration of opioid antagonists and psychosocial therapy in the treatment of alcohol and narcotic dependence, J Clin Psychiatry, 56, 30
- O'Malley, 1995, Naltrexone in the treatment of alcohol dependence: A combined analysis of two trials, Psychiatr Ann, 25, 681, 10.3928/0048-5713-19951101-11 · DOI
- O'Malley, 1996, Six month follow-up of naltrexone and psychotherapy for alcohol dependence, Arch Gen Psychiatry, 53, 217, 10.1001/archpsyc.1996.01830030039007 · DOI · Paper page
- O'Malley, 1992, Naltrexone and coping skills therapy for alcohol dependence: A controlled study, Arch Gen Psychiatry, 49, 881, 10.1001/archpsyc.1992.01820110045007 · DOI · Paper page
- O'Malley, 1996, Experience of a `slip' among alcoholics treated with naltrexone or placebo, Am J Psychiatry, 153, 281, 10.1176/ajp.153.2.281 · DOI · Paper page
- Paille, 1995, Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol, Alcohol Alcohol, 30, 239
- Pfohl, 1986, Naltrexone hydrochloride (Trexan): A review of serum transaminase elevations at high dosage
- Pottenger, 1978, The frequency and persistence of depressive symptoms in the alcohol abuser, J Nerv Ment Dis, 166, 562, 10.1097/00005053-197808000-00003 · DOI · Paper page
- Pristach, 1983, Alcohol withdrawal syndromes—prediction from detailed medical and drinking histories, Drug Alcohol Depend, 11, 177, 10.1016/0376-8716(83)90078-9 · DOI
- Racine, 1978, Kindling: The first decade, Neurosurgery, 3, 234, 10.1227/00006123-197809000-00018 · DOI · Paper page
- Rathlev, 1994, The lack of efficacy of phenytoin in the prevention of recurrent alcohol withdrawal seizures, Ann Emerg Med, 23, 513, 10.1016/S0196-0644(94)70070-2 · DOI
- Ritson, 1986, Comparison of two benzodiazepines in the treatment of alcohol withdrawal: Effects on symptoms and cognitive recovery, Drug Alcohol Depend, 18, 329, 10.1016/0376-8716(86)90095-5 · DOI
- Rosenfeld, 1961, A controlled study of alcohol withdrawal, Q J Stud Alcohol, 1, 77, 10.15288/qjsas.1961.s1.077 · DOI
- Ryzen, 1985, Magnesium deficiency in a medical ICU population, Crit Care Med, 13, 19, 10.1097/00003246-198501000-00006 · DOI · Paper page
- Saitz, 1995, Recognition and management of occult alcohol withdrawal, Hosp Pract, 30, 49, 10.1080/21548331.1995.11443214 · DOI
- Saitz, 1995, Alcohol withdrawal: A nationwide survey of inpatient treatment practices, J Gen Intern Med, 10, 479, 10.1007/BF02602395 · DOI
- Saitz, 1995, Clinical features associated with alcohol withdrawal duration [abstr], J Gen Intern Med, 10, 48
- Saitz, 1994, Individualized treatment for alcohol withdrawal: A randomized double-blind controlled trial, JAMA, 272, 519, 10.1001/jama.1994.03520070039035 · DOI · Paper page
- Sampliner, 1974, Diphenylhydantoin control of alcohol withdrawal seizures: Results of a controlled study, JAMA, 230, 1430, 10.1001/jama.1974.03240100048028 · DOI
- Sellers, 1983, Diazepam loading: Simplified treatment of alcohol withdrawal, Clin Pharmacol Ther, 34, 822, 10.1038/clpt.1983.256 · DOI · Paper page
- Sellers, 1981, Drugs to decrease alcohol consumption, N Engl J Med, 305, 1255, 10.1056/NEJM198111193052105 · DOI
- Sellers, 1994, Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence, Alcohol Clin Exp Res, 18, 879, 10.1111/j.1530-0277.1994.tb00054.x · DOI · Paper page
- Sereny, 1965, Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol withdrawal syndrome, BMJ, 1, 92, 10.1136/bmj.1.5427.92 · DOI · Paper page
- Shaw, 1987, Tiapride in the long-term management of alcoholics of anxious or depressive temperament, Br J Psychiatry, 150, 164, 10.1192/bjp.150.2.164 · doi:10.1192/bjp.150.2.164
- Shaw, 1981, Development of optimal treatment tactics for alcohol withdrawal: I. Assessment and effectiveness of supportive care, J Clin Psychopharmacol, 1, 382, 10.1097/00004714-198111000-00006 · DOI · Paper page
- Solomon, 1983, Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome, Clin Ther, 6, 52
- Soyka, 1989, Epileptic seizures and alcohol withdrawal: Significance of additional use (and misuse) of drugs and electroencephalographic findings, J Epilepsy, 2, 109, 10.1016/0896-6974(89)90046-7 · DOI
- Sparadeo, 1982, Evaluation of a social-setting detoxification program, J Stud Alcohol, 43, 1124, 10.15288/jsa.1982.43.1124 · DOI
- Sternebring, 1983, Reduction in early alcohol abstinence fits by administration of carbamazepine syrup instead of tablets, Eur J Clin Pharmacol, 24, 611, 10.1007/BF00542209 · doi:10.1007/bf00542209
- Stockwell, 1991, Home detoxification from alcohol: Its safety and efficacy in comparison with inpatient care, Alcohol Alcohol, 26, 645, 10.1093/oxfordjournals.alcalc.a045169 · DOI
- Stockwell, 1983, The severity of alcohol dependence questionnaire: Its use, reliability and validity, Br J Addic, 78, 145, 10.1111/j.1360-0443.1983.tb05502.x · DOI · Paper page
- Stuppaeck, 1992, Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: A double blind study, Alcohol Alcohol, 27, 153
- Sullivan, 1991, Benzodiazepine requirements during alcohol withdrawal syndrome: Clinical implications of using a standardized withdrawal scale, J Clin Psychopharmacol, 11, 291, 10.1097/00004714-199110000-00003 · DOI · Paper page
- Thompson, 1975, Diazepam and paraldehyde for treatment of severe delirium tremens: A controlled trial, Ann Intern Med, 82, 175, 10.7326/0003-4819-82-2-175 · DOI · Paper page
- Thorp, 1995, Management of drug dependency, overdose, and withdrawal in the obstetric patient, Obstet Gynecol Clin North Am, 22, 131, 10.1016/S0889-8545(21)00559-3 · DOI
- Tsai, 1995, The glutamatergic basis of human alcoholism, Am J Psychiatry, 152, 332, 10.1176/ajp.152.3.332 · DOI · Paper page
- Umbricht-Schneiter, 1991, Alcohol abuse: Comparison of two methods for assessing prevalence and associated morbidity in hospitalized patients, Am J Med, 91, 110, 10.1016/0002-9343(91)90002-F · DOI
- Victor, 1953, The effect of alcohol on the nervous system, Res Publ Assoc Res Nerv Ment Dis, 32, 526
- Victor, 1967, The role of abstinence in the genesis of alcoholic epilepsy, Epilepsia, 8, 1, 10.1111/j.1528-1157.1967.tb03815.x · DOI · Paper page
- Vinson, 1991, Admission alcohol level: A predictor of the course of alcohol withdrawal, J Fam Pract, 33, 161
- Volpicelli, 1995, Naltrexone in the treatment of alcoholism: Predicting response to naltrexone, J Clin Psychiatry, 56, 39
- Wartenberg, 1990, Detoxification of alcoholics: Improving care by symptom-triggered sedation, Alcohol Clin Exp Res, 14, 71, 10.1111/j.1530-0277.1990.tb00449.x · DOI
- Wetterling, 1994, Clinical predictors of alcohol withdrawal delirium, Alcohol Clin Exp Res, 18, 1100, 10.1111/j.1530-0277.1994.tb00087.x · DOI
- Whang, 1985, Magnesium depletion as a cause of refractory potassium repletion, Arch Intern Med, 145, 1686, 10.1001/archinte.1985.00360090162024 · doi:10.1001/archinte.1985.00360090162024
- Whitfield, 1978, Detoxification of 1024 alcoholic patients without psychoactive drugs, JAMA, 239, 1409, 10.1001/jama.1978.03280410051018 · DOI · Paper page
- Whitworth, 1996, Comparison of alcamprosate and placebo in long-term treatment of alcohol dependence, Lancet, 347, 1438, 10.1016/S0140-6736(96)91682-7 · DOI · Paper page
- Williams, 1984, Alcoholic hypoglycemia and ketoacidosis, Med Clin North Am, 68, 33, 10.1016/S0025-7125(16)31239-1 · DOI · Paper page
- Wilson, 1984, A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome, Alcohol Clin Exp Res, 8, 542, 10.1111/j.1530-0277.1984.tb05726.x · DOI · Paper page
- Wilson, 1985, Double-blind trial of alprazolam and chlordiazepoxide in the management of the acute ethanol withdrawal syndrome, Alcohol Clin Exp Res, 9, 23, 10.1111/j.1530-0277.1985.tb05043.x · DOI · Paper page
- Wrenn, 1989, A toxicity study of parenteral thiamine hydrochloride, Ann Emerg Med, 18, 867, 10.1016/S0196-0644(89)80215-X · DOI
- Zeise, 1993, Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rate neocortex: Possible involvement of excitatory amino acid receptors, Eur J Pharmacol, 231, 47, 10.1016/0014-2999(93)90682-8 · DOI · Paper page
- Zilm, 1980, Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal, Alcohol Clin Exp Res, 4, 400, 10.1111/j.1530-0277.1980.tb04839.x · DOI · Paper page
Cited by
The Status of Disulfiram: A Half of a Century Later
Suh, J. J., Pettinati, H. M., Kampman, K. M., & O'Brien, C. P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222512.25649.08 · Cited by 382
GHB: a new and novel drug of abuse
Nicholson, K. L., & Balster, R. L. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00191-5 · Cited by 320
FRIEDLANDER, A. H., MARDER, S. R., PISEGNA, J. R., & YAGIELA, J. A. (2003) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2003.0260 · Cited by 269
Intranasal oxytocin blocks alcohol withdrawal in human subjects
Pedersen, C. A., Smedley, K. L., Leserman, J., Jarskog, L. F., Rau, S. W., Kampov‐Polevoi, A., Casey, R. L., Fender, T., & Garbutt, J. C. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01958.x · Cited by 196
Clinical management of alcohol withdrawal: A systematic review
Bharadwaj, B., & Kattimani, S. (2013) · Industrial Psychiatry Journal · doi:10.4103/0972-6748.132914 · Cited by 154
“Although, a single lorazepam dose given is likely to prevent further seizure recurrences, it may still be required to give SML dose of diazepam of at least 20 [13] -60 mg [27] or at times even 80 mg diazepam [7] in such patients.”
Influential
Metadata
- Authors
- Saitz, R., & O'Malley, S. S.
- Venue
- Medical Clinics of North America
- Publisher
- Elsevier BV
- Published
- 1997-07
- Volume
- 81
- Issue
- 4
- Pages
- 881-907
- ISSN
- 0025-7125 (ISSN-L)
- OpenAlex
- W106360673
- Cited by
- 129
- References
- 8
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 2906 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PHARMACOTHERAPIES FOR ALCOHOL ABUSE. https://app.cochat.ai/papers/10.1016/s0025-7125(05)70554-x
- The paper
- Saitz, R., & O'Malley, S. S. (1997). PHARMACOTHERAPIES FOR ALCOHOL ABUSE. Medical Clinics of North America. https://doi.org/10.1016/s0025-7125(05)70554-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.